MX2022001204A - Métodos de identificación de receptores de linfocitos t. - Google Patents

Métodos de identificación de receptores de linfocitos t.

Info

Publication number
MX2022001204A
MX2022001204A MX2022001204A MX2022001204A MX2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A
Authority
MX
Mexico
Prior art keywords
methods
identifying
mhc class
certain aspects
beta chain
Prior art date
Application number
MX2022001204A
Other languages
English (en)
Spanish (es)
Inventor
Naoto Hirano
Kenji Sugata
Munehide Nakatsugawa
Yuki Yamashita
Muhammed Aashiq Rahman
Original Assignee
Univ Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Health Network filed Critical Univ Health Network
Publication of MX2022001204A publication Critical patent/MX2022001204A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/32—T-cell receptors [TCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051—T-cell receptor (TcR)-CD3 complex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70539—MHC-molecules, e.g. HLA-molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2022001204A 2019-07-30 2020-07-29 Métodos de identificación de receptores de linfocitos t. MX2022001204A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962880492P 2019-07-30 2019-07-30
US202063029103P 2020-05-22 2020-05-22
PCT/IB2020/057176 WO2021019476A1 (en) 2019-07-30 2020-07-29 Methods of identifying t cell receptors

Publications (1)

Publication Number Publication Date
MX2022001204A true MX2022001204A (es) 2022-05-03

Family

ID=74228602

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022001204A MX2022001204A (es) 2019-07-30 2020-07-29 Métodos de identificación de receptores de linfocitos t.

Country Status (11)

Country Link
US (1) US20220291215A1 (cg-RX-API-DMAC10.html)
EP (1) EP4004546A4 (cg-RX-API-DMAC10.html)
JP (2) JP7724203B2 (cg-RX-API-DMAC10.html)
KR (1) KR102985224B1 (cg-RX-API-DMAC10.html)
CN (1) CN114761802B (cg-RX-API-DMAC10.html)
AU (1) AU2020321710A1 (cg-RX-API-DMAC10.html)
CA (1) CA3146290A1 (cg-RX-API-DMAC10.html)
IL (1) IL290226A (cg-RX-API-DMAC10.html)
MX (1) MX2022001204A (cg-RX-API-DMAC10.html)
TW (1) TW202118779A (cg-RX-API-DMAC10.html)
WO (1) WO2021019476A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020231693A1 (en) 2019-03-04 2021-09-30 University Health Network T cell receptors and methods of use thereof
TWI881991B (zh) * 2019-07-30 2025-05-01 大學健康網絡 Ii類mhc分子及其使用方法
TW202116797A (zh) 2019-07-30 2021-05-01 大學健康網絡 Ii類mhc分子及其使用方法
CN118662607B (zh) * 2023-03-15 2026-07-07 中国科学院上海药物研究所 抑制过激炎性反应的蛋白及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012120488A (ja) * 2010-12-09 2012-06-28 Univ Of Tokyo 新規安定化組換えmhcタンパク質
AU2018335274B2 (en) * 2017-09-20 2025-02-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HLA class II–restricted T cell receptors against mutated RAS
TW202116797A (zh) * 2019-07-30 2021-05-01 大學健康網絡 Ii類mhc分子及其使用方法

Also Published As

Publication number Publication date
CN114761802A (zh) 2022-07-15
CN114761802B (zh) 2026-04-28
WO2021019476A1 (en) 2021-02-04
JP2025166836A (ja) 2025-11-06
KR20220052941A (ko) 2022-04-28
JP7724203B2 (ja) 2025-08-15
EP4004546A1 (en) 2022-06-01
JP2022542445A (ja) 2022-10-03
US20220291215A1 (en) 2022-09-15
IL290226A (en) 2022-03-01
TW202118779A (zh) 2021-05-16
KR102985224B1 (ko) 2026-07-02
CA3146290A1 (en) 2021-02-04
EP4004546A4 (en) 2024-10-09
AU2020321710A1 (en) 2022-03-03

Similar Documents

Publication Publication Date Title
CO2022000281A2 (es) Receptores de linfocitos t de mage-a4 y métodos de uso de estos
MX2021005155A (es) Anticuerpo biespecífico y uso del mismo.
CR20170351A (es) Proteínas de unión a icos
MX2020010235A (es) Vectores de expresion para receptores de engullimiento quimerico, celulas hospederas geneticamente modificadas y usos de los mismos.
MX2014014801A (es) Metodo para la seleccion y produccion de entidades dirigidas altamente selectivas hechas a la medida y multiespecificas que contienen por lo menos dos entidades de union diferentes y usos de las mismas.
CY1121962T1 (el) Υποδοχεις τ κυτταρου
EA202091335A1 (ru) Ограниченные hla класса i t-клеточные рецепторы против мутантного ras
PE20191651A1 (es) Anticuerpos agonistas anti-icos y sus usos
TR201911010A2 (tr) Benzeti̇lmi̇ş tavlama tabanli bi̇r yaklaşimla bulutta görev çi̇zelgeleme yapilmasini sağlayan yöntem
BR112022001702A2 (pt) Moléculas mhc classe ii e métodos de uso das mesmas
MX2023000738A (es) Proteinas de union a antigeno que activan el receptor de leptina.
BR112012017124B8 (pt) método para produzir e para purificar um multímero polipeptídico
EA202090652A1 (ru) T-клеточные рецепторы, рестриктированные по антигену лейкоцитов человека класса ii, против мутантного ras
AR083295A1 (es) Metodo para activar celulas t auxiliares
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
EA201390011A1 (ru) Т-клеточные рецепторы
CR20220330A (es) Anticuerpos anti-ly6g6d y métodos de uso.
MX2022001210A (es) Moléculas de complejo mayor de histocompatibilidad (mhc) de clase ii y métodos para su uso.
SA519410534B1 (ar) أجسام مضادة لعامل مساعد لموهن الخلايا الليمفاوية البائية والتائية واستخداماتها
CL2025001526A1 (es) Composición para inmunoterapia
BR112013004594A2 (pt) método para a determinação de um conteúdo de antígeno
CR20220065A (es) Método para la caracterización de polipéptidos que se unen a complejos de péptido:mhc
WO2018160874A8 (en) CLASSIFICATION OF CELLS BASED ON A MECHANICAL SIGNATURE OF THE CORE
ZA202102546B (en) Methods for identifying free thiols in proteins
BR112016018826A8 (pt) anticorpo purificado, ou fragmento de ligação de antígeno, método para a identificação de uma população de células de esperma de mamífero portadoras de cromossomo x, e método in vitro para distorcer uma proporção entre os sexos